GPC3 and hepatocellular carcinoma: GPC3 is a promising HCC-selective biomarker, and a number of groups have exploited this feature to generate vaccines, HCC-selective antibodies, and peptides for imaging and therapy (Table 1).25 Several peptides with putative specificity to GPC3 have been reported in the literature.